Plasma Levels of Parent Compound and Metabolites after Doses of Either d-Fenfluramine or d-3,4-Methylenedioxymethamphetamine (MDMA) that Produce Long-Term Serotonergic Alterations

This publication has 34 references indexed in Scilit:

• Amphetamine Derivative Fatalities in South Australia-Is "Ecstasy" the Culprit?
  American Journal of Forensic Medicine & Pathology, 1998
• Determination of d-fenfluramine, d-norfenfluramine and fluoxetine in plasma, brain tissue and brain microdialysate using high-performance liquid chromatography after precolumn derivatization with dansyl chloride
  Journal of Chromatography B: Biomedical Sciences and Applications, 1997
• Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion
  Biochemical Pharmacology, 1996
• The use of toxicokinetics for the safety assessment of drugs acting in the brain
  Molecular Neurobiology, 1995
• Oral kinetics of dexfenfluramine and dexnorfenfluramine in non-human primates
  Xenobiotica, 1995
• Oral administration of 3,4-methylenedioxymethamphetamine (MDMA) produces selective serotonergic depletion in the nonhuman primate
  Neurotoxicology and Teratology, 1993
• Multiple severe complications from recreational ingestion of MDMA ('Ecstasy')
  Published by American Medical Association (AMA) ,1987
• Regional distribution of monoamines in the cerebral cortex and subcortical structures of the rhesus monkey: concentrations and in vivo synthesis rates
  Brain Research, 1979
• FENFLURAMINE AND BRAIN SEROTONIN
  Annals of the New York Academy of Sciences, 1978
• Fenfluramine: Long-term reduction in brain serotonin (5-hydroxytryptamine)
  European Journal of Pharmacology, 1976